We are live on
!
Find out more
BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
6 hedge funds and large institutions have $15.2M invested in bluebird bio in 2013 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Ameriprise
Minneapolis,
Minnesota
| $8.07M | +$8.23M | +24,946 | New |
|
|
CCM
2
Camber Capital Management
Boston,
Massachusetts
| $3.75M | +$3.82M | +11,580 | New |
|
3
Citadel Advisors
Miami,
Florida
| $1.25M | +$1.27M | +3,859 | New |
|
4
Alyeska Investment Group
Chicago,
Illinois
| $749K | +$764K | +2,316 | New |
|
|
MCM
5
Mazama Capital Management
Portland,
Oregon
| $749K | +$764K | +2,316 | New |
|
|
EEG
6
E.E. Geduld
| $643K | +$656K | +1,988 | New |
|
BLUE Hedge Fund Activity: Q2 2013 in Review
6 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in bluebird bio (BLUE) for Q2 2013, worth a combined $15.2M.
Buyers outnumbered sellers: 6 funds opened new BLUE positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
- 6 institutional investors held bluebird bio (BLUE) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $15.2M of bluebird bio stock for Q2 2013.
- 6 funds opened new bluebird bio positions in Q2 2013 and 0 closed out, a net change of +6 holders.
Based on aggregated 13F filings for Q2 2013.